Crinetics | News & Events

PRESS RELEASES

Press Release | May 21, 2019

Crinetics Pharmaceuticals Initiates Phase 1 Study of CRN01941 for the Treatment of Neuroendocrine Tumors

Press Release | May 13, 2019

Crinetics Pharmaceuticals Reports First Quarter 2019 Financial Results and Provides Corporate Update

Press Release | March 19, 2019

Crinetics Pharmaceuticals Doses First Patients in Phase 2 Clinical Trials of CRN00808 for Acromegaly

Press Release | March 18, 2019

Crinetics Pharmaceuticals Appoints Gina Ford, RPh, MBA, as Vice President, Corporate Strategy and Commercial Planning

Press Release | March 14, 2019

Crinetics Pharmaceuticals Announces Upcoming Presentations at ENDO2019

Press Release | March 13, 2019

Crinetics Pharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Corporate Update

Press Release | February 21, 2019

Crinetics Pharmaceuticals to Present at SVB Leerink Global Healthcare Conference

Press Release | January 2, 2019

Crinetics Pharmaceuticals to Present at J.P. Morgan Healthcare Conference

Press Release | November 3, 2018

Crinetics Pharmaceuticals Reports Third Quarter 2018 Financial Results and Provides Corporate Update

Press Release | September 26, 2018

Crinetics Pharmaceuticals to Present at Leerink Partners Roundtable Series: Rare Disease & Oncology

21 / 24

Transforming Endocrine Disease Treatment

Be the first to know about the advances we're making in endocrine-rooted care.

Email Signup